{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:29:48Z","timestamp":1773934188740,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jceh.2025.103431","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:24:21Z","timestamp":1764721461000},"page":"103431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-alcoholic Fatty Liver Disease in Pregnancy: Clinical Implications, Adverse Outcomes, and Therapeutic Considerations"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-3429","authenticated-orcid":false,"given":"Diego F.","family":"Wyszynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.103431_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/147323000303100610","article-title":"A new approach to drug therapy in non-alcoholic steatohepatitis (NASH)","volume":"31","author":"Feh\u00e9r","year":"2003","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jceh.2025.103431_bib2","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103431_bib3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103431_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103431_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2020.03.049","article-title":"Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes","volume":"73","author":"Sarkar","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103431_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jceh.2015.02.002","article-title":"The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"5","author":"Sharma","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103431_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3350\/cmh.2021.0205","article-title":"Systematic review with meta-analysis: non-Alcoholic fatty liver disease and the association with pregnancy outcomes","volume":"28","author":"El Jamaly","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib10","first-page":"221","article-title":"Implications of nonalcoholic fatty liver disease on pregnancy and maternal and child outcomes","volume":"15","author":"Hershman","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2022-000913","article-title":"Fatty liver index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy","volume":"9","author":"Koralegedara","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215326","article-title":"Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: a cross sectional analytical study","volume":"14","author":"Herath","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.103431_bib24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/MEG.0000000000002802","article-title":"Cardiovascular complications during delivery hospitalizations in patients with nonalcoholic fatty liver disease in pregnancy","volume":"36","author":"Niu","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib18","first-page":"487","article-title":"[Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk factor abnormalities with adverse pregnancy outcomes]","volume":"57","author":"Yang","year":"2025","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jceh.2025.103431_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5114\/ceh.2021.109228","article-title":"Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis","volume":"7","author":"Dyah","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib21","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.cgh.2021.11.007","article-title":"Metabolic dysfunction-associated fatty liver disease and subsequent development of adverse pregnancy outcomes","volume":"20","author":"Lee","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000831","article-title":"Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages-prospective study in rajarata pregnancy cohort (RaPCo)","volume":"9","author":"Koralegedara","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib14","first-page":"180","article-title":"Pregnancy outcome in patients with non-alcoholic fatty liver disease: a prospective cohort study","volume":"17","author":"Mohammad Jafari","year":"2024","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.jceh.2025.103431_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00125-018-4779-8","article-title":"Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus","volume":"62","author":"Lee","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jceh.2025.103431_bib16","article-title":"The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus","volume":"16","author":"Li","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.103431_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12916-023-02818-6","article-title":"Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women","volume":"21","author":"Wu","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.jceh.2025.103431_bib33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/jgh.16163","article-title":"Non-alcoholic steatohepatitis is independently associated with a history of gestational diabetes mellitus","volume":"38","author":"Boustany","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib34","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.14309\/ajg.0000000000002250","article-title":"History of gestational diabetes and incident nonalcoholic fatty liver disease: the kangbuk samsung health study","volume":"118","author":"Cho","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cgh.2023.03.031","article-title":"Prevalence, risk profiles, and national implications of nonalcoholic fatty liver disease in pregnant individuals","volume":"22","author":"Kushner","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib23","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/j.cgh.2021.01.022","article-title":"NAFLD cirrhosis is rising among childbearing women and is the Most common cause of cirrhosis in pregnancy","volume":"20","author":"Sarkar","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib25","series-title":"Abstract Sa 1562, Presented at Digestive Disease Week","article-title":"Intrahepatic cholestasis of pregnancy (ICP) is associated with higher prevalence of NAFLD: a case-control study","author":"Monrose","year":"2019"},{"key":"10.1016\/j.jceh.2025.103431_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7090275","article-title":"Association of pre-eclampsia with carotid artery intima-media thickness and non-alcoholic fatty liver disease","volume":"7","author":"Memari","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2025.103431_bib31","article-title":"Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.103431_bib30","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1007\/s00431-023-05044-7","article-title":"Evaluation of 2-year outcomes in infants born to mothers with and without NAFLD in pregnancy","volume":"182","author":"Gross","year":"2023","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jceh.2025.103431_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ebiom.2017.11.014","article-title":"Liver dysfunction during pregnancy and its association of with preterm birth in China: a prospective cohort study","volume":"26","author":"Zhuang","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jceh.2025.103431_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jim-2019-001186","article-title":"Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy","volume":"68","author":"Sattari","year":"2020","journal-title":"J Invest Med"},{"key":"10.1016\/j.jceh.2025.103431_bib26","article-title":"The impact of the association between nonalcoholic fatty liver disease and intrahepatic cholestasis of pregnancy on maternal and fetal outcomes","volume":"15","author":"Koushik","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2025.103431_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2025.103431_bib28","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/hep.26617","article-title":"Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study","volume":"59","author":"Geenes","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103431_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17446651.2024.2365791","article-title":"Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review","volume":"19","author":"Leca","year":"2024","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.jceh.2025.103431_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12902-024-01569-6","article-title":"Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jceh.2025.103431_bib37","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cgh.2020.08.012","article-title":"Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population","volume":"19","author":"Wang","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/AOG.0000000000000565","article-title":"Postpartum weight retention risk factors and relationship to obesity at 1 year","volume":"125","author":"Endres","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jceh.2025.103431_bib39","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.fertnstert.2014.02.047","article-title":"Differences in ovarian hormones in relation to parity and time since last birth","volume":"101","author":"Barrett","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jceh.2025.103431_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/20420188241274350","article-title":"Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives","volume":"15","author":"Zhang","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jceh.2025.103431_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2020.02.011","article-title":"Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease","volume":"68","author":"Lao","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jceh.2025.103431_bib42","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1440-1746.2010.06253.x","article-title":"A fresh look at NASH pathogenesis. Part 1: the metabolic movers","volume":"25","author":"Larter","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jhep.2017.03.023","article-title":"Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis","volume":"67","author":"Kim","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/emph\/eoae001","article-title":"Host-gut microbiota interactions during pregnancy","volume":"12","author":"Amato","year":"2024","journal-title":"Evol Med Public Health"},{"key":"10.1016\/j.jceh.2025.103431_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103431_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.14309\/ajg.0000000000000101","article-title":"Noninvasive tests for prognosticating outcomes in patients with chronic liver disease in pregnancy: ready for prime time?","volume":"114","author":"Kushner","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2016.10.016","article-title":"Outcomes of pregnancies for women undergoing endoscopy while they were pregnant: a nationwide cohort study","volume":"152","author":"Ludvigsson","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103431_bib48","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103431_bib50","first-page":"Cd007145","article-title":"Diet or exercise, or both, for preventing excessive weight gain in pregnancy","volume":"2015","author":"Muktabhant","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2025.103431_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1081096","article-title":"Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Chai","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jceh.2025.103431_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clnesp.2023.10.001","article-title":"Investigation about the correlation between the severity of metabolic-associated fatty liver disease and adherence to the mediterranean diet","volume":"58","author":"Mokhtare","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.jceh.2025.103431_bib54","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib55","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jceh.2025.103431_bib56","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jada.2010.06.008","article-title":"Fructose: metabolic, hedonic, and societal parallels with ethanol","volume":"110","author":"Lustig","year":"2010","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jceh.2025.103431_bib57","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jhep.2013.11.033","article-title":"Dietary glycotoxins exacerbate progression of experimental fatty liver disease","volume":"60","author":"Leung","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib58","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.3748\/wjg.v30.i23.2964","article-title":"Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease","volume":"30","author":"Rocho\u0144","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75542-3","article-title":"Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid","volume":"10","author":"Iwao","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2025.103431_bib60","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/1389201020666190311143554","article-title":"Combined amelioration of ginsenoside (rg1, Rb1, and Rg3)-enriched Korean red ginseng and probiotic lactobacillus on non-alcoholic fatty liver disease","volume":"20","author":"Kim","year":"2019","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jceh.2025.103431_bib61","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","article-title":"Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases","volume":"39","author":"Loguercio","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","article-title":"Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review","volume":"66","author":"Hashida","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.metabol.2017.08.012","article-title":"Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - a randomized trial","volume":"78","author":"Winn","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2025.103431_bib64","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ajg.2010.488","article-title":"Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease","volume":"106","author":"Kistler","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2088","article-title":"Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence","volume":"344","author":"Thangaratinam","year":"2012","journal-title":"Bmj"},{"key":"10.1016\/j.jceh.2025.103431_bib66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dbi18-0043","article-title":"Exercise combats hepatic steatosis: potential mechanisms and clinical implications","volume":"69","author":"Thyfault","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2025.103431_bib67","doi-asserted-by":"crossref","first-page":"G387","DOI":"10.1152\/ajpgi.00089.2016","article-title":"A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats","volume":"311","author":"Linden","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2025.103431_bib68","doi-asserted-by":"crossref","first-page":"R763","DOI":"10.1152\/ajpregu.00537.2012","article-title":"Hepatic steatosis development with four weeks of physical inactivity in previously active, hyperphagic OLETF rats","volume":"304","author":"Linden","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jceh.2025.103431_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29225245","article-title":"Quercetin: a promising candidate for the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"29","author":"Markowska","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jceh.2025.103431_bib70","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1345\/aph.1K045","article-title":"Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?","volume":"41","author":"Feig","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jceh.2025.103431_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1218432","article-title":"Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects","volume":"14","author":"Shan","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jceh.2025.103431_bib72","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S2468-1253(21)00074-1","article-title":"Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis","volume":"6","author":"Ovadia","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib73","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.jceh.2025.103431_bib74","article-title":"LiverTox, Clinical and research information on drug-induced liver injury. Bethesda (MD)","year":"2012","journal-title":"Nat Inst Diabetes Dig Kidney Dis"},{"key":"10.1016\/j.jceh.2025.103431_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26502\/aimr.0189","article-title":"Semaglutide: double-edged sword with risks and benefits","volume":"8","author":"Pillarisetti","year":"2025","journal-title":"Arch Intern Med Res"},{"key":"10.1016\/j.jceh.2025.103431_bib77","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.2004.02025.x","article-title":"Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial","volume":"20","author":"Nair","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2025.103431_bib79","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1756283X09105462","article-title":"The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial","volume":"2","author":"Shields","year":"2009","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib81","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103431_bib82","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103431_bib83","first-page":"Cd004069","article-title":"Vitamin E supplementation in pregnancy","volume":"2015","author":"Rumbold","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2025.103431_bib84","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1111\/bcp.15423","article-title":"Pregnancy outcomes following maternal exposure to statins: a systematic review and meta-analysis","volume":"88","author":"Karadas","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jceh.2025.103431_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.101997","article-title":"Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: an NHANES analysis","volume":"46","author":"Sourianarayanane","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103431_bib86","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186426","article-title":"Metabolic dysfunction-associated steatotic liver disease and pregnancy","volume":"135","author":"Sarkar","year":"2025","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jceh.2025.103431_bib87","article-title":"Accuracy of ultrasonography vs. elastography in patients with non-alcoholic fatty liver disease: a systematic review","volume":"14","author":"Geethakumari","year":"2022","journal-title":"Cureus"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325009314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325009314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:14:41Z","timestamp":1773926081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325009314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0973688325009314"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103431","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic Fatty Liver Disease in Pregnancy: Clinical Implications, Adverse Outcomes, and Therapeutic Considerations","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103431"}}